Transutricular Seminal-Vesiculoscopy in the Management of Hematospermia.
- Author:
Sang Kwon BYON
1
;
Koon Ho RHA
;
Seung Choul YANG
Author Information
1. Department of Urology, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Hematospermia;
Endoscopy;
Seminal vesicles
- MeSH:
Calculi;
Ejaculation;
Ejaculatory Ducts;
Endoscopy;
Epididymitis;
Hemorrhage;
Hemospermia*;
Humans;
Magnetic Resonance Imaging;
Male;
Postoperative Complications;
Prostatitis;
Seminal Vesicles;
Ultrasonography;
Ureteroscopes
- From:Korean Journal of Urology
2001;42(3):329-333
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the etiology and treatment of options in patients with hematospermia, we performed endoscopy of the seminal vesicles in 37 patients with hematospermia. MATERIALS AND METHODS: The patients were evaluated with either transrectal ultrasound (TRUS) or endorectal MRI. Mean age was 47.1 years (range 28-68 years) with duration of infliction being 37 months (range 3 months to 10 years). When the patients who had the definite abnormalities on the imaging studies and did not improve by medications for more than 3 months, transutricular seminal-vesiculoscopy using 6Fr or 9Fr rigid ureteroscope was performed. Patients were followed for more than 3 months after the endoscopic treatment. RESULTS: Hemorrhage was found in the seminal vesicles and the ejaculatory ducts in 23 (62.2%) and 3 (8.1%), respectively. Calculi were present in the seminal vesicles and the ejaculatory ducts in 6 (16.2%) and 2 (5.4%), respectively. Prostatitis was present in 9 (24.3%) patients. All patients except one reported improvement of hematospermia. Postoperative complications including epididymitis or retrograde ejaculation were not observed. CONCLUSIONS: Our series is the first large-scale experience of the seminal vesicle endoscopy in vivo. Transutricular seminal vesiculoscopy can be performed easily with conventional endoscopic equipment. The endoscopic evaluation and management of the hematospermia is a viable clinical option.
